We are pleased to announce that our proposal “Development of novel pharmacotherapy to prevent development of severe conditions in patients with COVID-19 and to improve long-term prognosis, and its companion diagnostics” was awarded R&D grant by the Japan Agency Medical Research and Development (AMED).

Link: https://www.amed.go.jp/koubo/01/06/0106C_00038.html

The development of effective treatment for COVID-19 is an urgent global matter. ARTham along with our collaborators is striving to establish an early diagnosis to identify high risk COVID-19 patients getting severe condition and develop an effective treatment to prevent development of severe conditions and to improve long-term prognosis.